Boundless Bio, Inc. Share Price

NASDAQ: BOLD

Small Cap

$1.14

-0.01

(-0.87%)

as on September 18, 2025 at 1:28 am IST

$₹

Boundless Bio, Inc. Stock Performance

as on September 18, 2025 at 1:28 am IST

Day's Low
Day's High
$1.12
Day's Price Range
$1.15
$1.14
1.75%
Downside
0.88%
Upside
52 Week's Low
52 Week's High
$1
52-Week Price Range
$4.72
$1.14
12.28%
Downside
314.04%
Upside

Boundless Bio, Inc. share price movements today

Previous Close: $1.15
Open: $1.13
Volume: 324.1K
Day's Low - High: $1.12 - $1.15
52 Week Low - High: $1 - $4.72

Boundless Bio, Inc. Historical Returns

1 Month Return: -0.86 %
3 Month Return: + 9.52 %
1 Year Return: -66.37 %
3 Year Return: 0 %
5 Year Return: 0 %

Boundless Bio, Inc. Stock Fundamentals & Key Indicators

Check Boundless Bio, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$26.2M

EPS (TTM)

-2.52

Dividend Yield

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

Return On Equity TTM

19410700.00%

Boundless Bio, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Boundless Bio, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Boundless Bio, Inc.	NA	$26.2M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	252.04%	-505.15	-12.96%
Beone Medicines Ltd	NA	$39.0B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$100.3B	44.17%	27.85	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	1.78%	14.1	31.37%

Stock Returns calculator for Boundless Bio, Inc. Stock including INR - Dollar returns

The Boundless Bio, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Boundless Bio, Inc. investment value today

Current value as on today

₹37,932

Returns

₹62,068

(-62.07%)

Returns from Boundless Bio, Inc. Stock

₹66,667 (-66.67%)

Dollar Returns*

₹4,598 (+4.6%)

Boundless Bio, Inc. Stock's Interest Amongst Investors

Search interest for Boundless Bio, Inc. Stock has decreased by -38% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 19, 2025 to September 18, 2025

Change:-38% versus previous 30 day period

Boundless Bio, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	-	-	-	-	1	-	-
Gross Profit	0	-	0	0	0	0	0	0	0	0
Operating Income	-12	-13	-14	-13	-16	-19	-18	-18	-17	-17
EBITDA	-11	-13	-14	-13	-16	-19	-18	-10	-17	-15
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-11	-12	-13	-12	-15	-16	-16	-16	-15	-15
Income Tax Expense	0	0	-1	-1	0	-	-	-	-	-
Net Income	-11	-12	-13	-12	-15	-16	-16	-16	-15	-15
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-1557.58%	0.00%	0.00%

Boundless Bio, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2014	Dec 2015	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	-
Gross Profit	-	-	0	0	0	-1
Operating Income	-	-	-25	-46	-54	-73
EBITDA	-	-	-24	-45	-48	-64
Interest Expense	-	-	-	-	-	-
Depreciation	-	-	0	0	0	1
Income Before Tax	-	-	-25	-45	-49	-65
Income Tax Expense	-	-	0	0	-5	-65
Net Income	-10	-26	-25	-45	-49	-65
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Boundless Bio, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-12	-13	-12	-15	-16	-16	-16	-15	-15
Operating Cash Flow	-10	-12	-11	-15	-16	-13	-15	-14	-11
Investing Cash Flow	-68	-7	15	18	-68	22	1	3	11
Financing Cash Flow	99	0	-1	0	90	0	0	-	0
Change in Cash	20	-20	2	1	6	8	-13	-11	0

Boundless Bio, Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-90	-128	-25	-45	-49	-65
Operating Cash Flow	-84	-107	-23	-39	-46	-60
Investing Cash Flow	-33	-185	-59	16	-38	-26
Financing Cash Flow	120	398	105	0	97	89
Change in Cash	2	105	22	-23	12	2

Insights on Boundless Bio, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.1% return, outperforming this stock by 134.5%
NEGATIVE IMPACT
Price Dip
In the last 1 year, BOLD stock has moved down by -66.4%

About Boundless Bio, Inc.

Boundless Bio, Inc. is a clinical-stage oncology company, which is engaged in cancer therapeutics that address the unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA (ecDNA). Using its proprietary Spyglass platform, it identifies targets essential for ecDNA functionality in oncogene amplified cancer cells, then designs and develops small molecule drugs called ecDNA-directed therapeutic candidates (ecDTx) to inhibit those targets. The Company’s lead therapeutic candidate ecDTx, BBI-355, is an oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells. BBI-355 demonstrated CHK1 inhibition and tumor regressions in oncogene amplified preclinical cancer models, including those enabled by ecDNA, and is being studied in a first-in-human, Phase I/II clinical trial in patients with oncogene amplified cancers. Its next program is directed at a previously undrugged kinesin target.

Organisation	Boundless Bio, Inc.
Headquarters	10955 Alexandria Way, San Diego, CA, United States, 92121
Industry	Health Technology
CEO	Mr. Zachary Hornby
E-voting on shares	Click here to vote

Key Management of Boundless Bio, Inc.

Name	Title
Ms. Jessica Oien J.D.	Chief Legal Officer & Corporate Secretary
Ms. Meredith Wesley	Senior Vice President of Talent & Culture
Dr. James L. Freddo M.D.	Interim Chief Medical Officer
Mr. Zachary Hornby	CEO, President & Director
Dr. Christian Hassig Ph.D.	Chief Scientific Officer
Mr. David Hinkle	Senior VP of Finance, Controller & Corporate Treasurer
Mr. Anthony Pinkerton Ph.D.	Senior Vice President of Drug Discovery
Ms. Amy Berkley Ph.D.	Senior Vice President of Program Team
Dr. Robert C. Doebele M.D., Ph.D.	Chief Medical Officer

FAQs

What is Boundless Bio, Inc. share price today?

Boundless Bio, Inc. share price today is $1.14 as on September 18, 2025 at 1:28 am IST at the close of the market. Boundless Bio, Inc. share today touched a day high of $1.15 and a low of $1.12.

What is the 52 week high and 52 week low for Boundless Bio, Inc. share?

Boundless Bio, Inc. share touched a 52 week high of $4.72 on September 20, 2024 and a 52 week low of $1 on June 24, 2025. Boundless Bio, Inc. stock price today i.e. September 18, 2025 at 1:28 am IST is closed at $1.14,which is 75.85% down from its 52 week high and 14.00% up from its 52 week low.

What is Boundless Bio, Inc.'s market capitalisation today?

Boundless Bio, Inc. market capitalisation is $0.00T as on September 18, 2025 at 1:28 am IST.

How to invest in Boundless Bio, Inc. Stock (BOLD) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Boundless Bio, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Boundless Bio, Inc. Shares that will get you 1.3158 shares as per Boundless Bio, Inc. share price of $1.14 per share as on September 18, 2025 at 1:28 am IST.

What is the minimum amount required to buy Boundless Bio, Inc. Stock (BOLD) from India?

Indian investors can start investing in Boundless Bio, Inc. (BOLD) shares with as little as ₹87.816 or $1 (as of September 18, 2025 at 2:38 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Boundless Bio, Inc. stock (as per the Rupee-Dollar exchange rate as on September 18, 2025 at 2:38 am IST). Based on Boundless Bio, Inc. share’s latest price of $1.14 as on September 18, 2025 at 1:28 am IST, you will get 8.7719 shares of Boundless Bio, Inc.. Learn more about fractional shares .